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How CD4+CD8+ thymocytes commit to CD4 helper l
tversus CD8 cytotoxic lineages is a central unresolved
question in developmental immunology. In this issue, l
fSarafova et al. (2005) show that engineering CD4 for
shutoff immediately after positive selection misdi- f
crects cells to the cytotoxic lineage. The result high-
lights the distinction between positive selection and C
elineage commitment and provides new impetus for re-
examining lineage models. (
h
Differentiation of double positive (DP, CD4+CD8+) thy- n
mmocytes into distinct T cell lineages with helper versus
cytotoxic functions serves as a paradigm for binary de- p
icisions in vertebrate development. However, this lin-
eage decision can only be understood in the context of
hthe requirement for DP cells to undergo positive selec-
tion following appropriate interactions with MHC-pep- t
dtide complexes. Following positive selection, DP cells,
which express αβ T cell antigen receptors (TCR), dif- c
Cferentiate into either MHC class II-restricted CD4+ T
helper cells or MHC class I-restricted CD8+ T cytotoxic p
scells by way of a CD4+8lo intermediate stage. The
mechanism by which such lineage commitment occurs 1
lhas been subject to long-standing and intense scrutiny,
and multiple models have been put forth. Although i
searly results were interpreted as supporting a stochas-
tic/selective mechanism of lineage choice, recent work i
ahas been most consistent with instructive models, in
which the CD4 and CD8 coreceptors transmit qualita- s
ttively or quantitatively different signals (Germain, 2002).
For example, differential recruitment of Lck by CD4 and 1
MCD8 would result in strong or weak TCR signaling and
in commitment to CD4 versus CD8 lineages (Hernan- t
bdez-Hoyos et al., 2000). Support for such a mechanism
in bipotential decisions comes from recent evidence m
Ithat quantitative signals contribute to the γδ vs. αβ T
cell developmental checkpoint (Robey, 2005). r
sA distinct model, based on temporal regulation of
signaling through the TCR:coreceptor complex, has p
abeen advanced by Singer and his colleagues (Singer,
2002). This “kinetic signaling” model postulates that lin- s
Teage commitment is determined by whether the TCR:MHC
interaction is sustained or truncated when, following posi- aive selection, cells progress to the CD4+8lo stage. Down-
egulation of CD8 would cause disruption of the
CR:MHCI interaction, resulting in a shorter signal and
ommitment to the CD8 lineage. Conversely, con-
inuous signaling due to the sustained CD4-dependent
CR:MHCII interaction would commit cells to the CD4
ineage. This model is the only one to explicitly suggest
hat a postpositive selection signal is responsible for
ineage commitment, although it is possible that signals
or selection and commitment are coupled. It is clear,
rom analysis of the hd/hd mutant mouse, in which all
lass II-specific thymocytes are misdirected to the
D8/cytotoxic lineage, that positive selection and lin-
age commitment are distinct and separable processes
Keefe et al., 1999). Models for lineage commitment
ave largely ignored the implications of this fact, but a
ew study by Sarafova et al. (2005) in this issue of Im-
unity highlights the importance of this distinction and
rovides new insights into the role of signaling follow-
ng positive selection.
Sarafova and her colleagues (Sarafova et al. 2005)
ave engineered a mouse in which they could examine
he contribution of CD4 expression following CD4-
ependent positive selection of MHC class II-specific
ells. They expressed CD4 under the regulation of a
D8 enhancer, E8III, previously shown to regulate re-
orter gene expression only in DP thymocytes and to
hut off following positive selection (Ellmeier et al.,
998). When this transgene was introduced into mice
acking endogenous CD4, expression of CD4 was lim-
ted to DP cells. In these mice, MHCII-directed positive
election remained intact, and CD4 was downregulated
n parallel with CD8. Remarkably, when these mice were
lso rendered deficient for β2m, such that all positive
election was directed by MHCII, most of the selected
hymocytes were redirected to the CD8 lineage (Figure
). When such mice additionally expressed a transgenic
HCII-specific TCR, that normally directs cells towards
he CD4/helper T cell lineage, all mature thymocytes
earing this receptor expressed CD8. In β2m-deficient
ice, CD8+ T cells are usually absent, and only class
I-specific CD4 lineage cells are present. The MHCII-
estricted unconventional CD8+ T cells were reduced
ignificantly in the periphery of the engineered mice,
resumably due to impaired transduction of TCR-medi-
ted homeostatic survival signals. Nevertheless, de-
pite being MHCII-restricted, the unconventional CD8+
cells had no CD40L expression, were able to mediate
strong cytotoxic response, and expressed levels of
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5Figure 1. Postpositive Selection CD4 Expression Is Required for
Commitment to the CD4 Lineage
(A) Positive selection of CD4+CD8+ thymocytes by MHCII or MHCI
leads to MHCII-restricted CD4+ or MHCI-restricted CD8+ T cells
through a CD4+8lo intermediate.
(B) In β2m-deficient mice, positive selection occurs only on MHCII,
and all thymocytes become MHCII-restricted CD4+ T cells.
(C) Sarafova and colleagues (Sarafova et al. 2005) find that when
positive selection is allowed to occur through CD4/TCR:MHCII in-
teractions followed by CD4 downregulation, all thymocytes be-
come MHCII-restricted CD8+ T cells.perforin and cathepsin W comparable to those in wild-
type CD8+ cells, suggesting that they had differentiated
into functional cytotoxic T cells. Thus, loss of expres-
sion of CD4 from transitional thymocytes immediately
postselection resulted in cells adopting the CD8/cyto-
toxic cell fate. These results clearly demonstrate that
CD4 expression is required after positive selection for
differentiation of the helper T cell lineage.
Sarafova et al. (2005) argue that their results are most
consistent with a kinetic signaling model in which lin-
eage commitment is determined solely by whether sig-
naling from the TCR persists or ceases. Despite the ele-
gant simplicity of this model, it remains possible that
qualitatively different signals occurring at different
stages of development result in positive selection ver-
sus lineage commitment. The transcription factor de-
fective in the hd mice, cKrox (also named Th-POK), is
required for commitment to the CD4 lineage, but not for
positive selection (He et al., 2005; Sun et al., 2005). Its
expression in CD4+8lo intermediate cells destined to
differentiate towards the CD4 lineage may be a result
of either prolonged TCR signaling or of a distinct signal
that could be mediated in part through the CD4 core-
ceptor. Sarafova et al. (2005) point out that in mice lack-
ing CD4 there is differentiation of MHCII-restricted CD4
“wannabe” T helper cells and conclude that CD4, per
se, is not required for commitment to the helper lin-
eage. This result is consistent with the kinetic signaling
model in that there would be sustained coreceptor-
independent signaling spanning positive selection and
the subsequent intermediate CD8lo stage, mediated by
high affinity TCR:MHCII interactions. However, the con-
verse example is not consistent with the model. Thus,
when positive selection of CD8-deficient thymocyteswas rescued by using higher affinity altered peptide li-
gands, the resulting MHC class I restricted cells were
CD8 “wannabe” thymocytes of the cytotoxic lineage,
not CD4+ helper cells (Goldrath et al., 1997). In addition,
a corollary of the result presented by Sarafova and col-
leagues is that sustained CD8 signaling after positive
selection should misdirect MHC class I-restricted T
cells to the CD4/helper lineage. Such an outcome has not
been clearly demonstrated. It therefore remains possible
that qualitative or quantitative differences in TCR and co-
receptor signals contribute to the lineage choice.
Significant advances have been made in identifying
transcription factors that contribute to lineage deci-
sions during thymocyte differentiation. Understanding
the mechanisms by which these molecules are regu-
lated will undoubtedly help to unravel how the CD4/
CD8 lineage choice is achieved. The present paper
firmly establishes that CD4-dependent signaling after
positive selection is required for differentiation of MHC
class II restricted thymocytes to the CD4 lineage. To-
gether with the recent studies on the role of cKrox in
CD4/helper cell differentiation, this new work raises in-
teresting questions that should now be testable. It will
be of particular interest to learn whether, following posi-
tive selection, CD8 lineage differentiation is a default
pathway that can be diverted to the helper lineage by
TCR/CD4-mediated signaling, or whether it is itself in-
duced by a distinct signal. A related question is whether
it will be possible to mimic a signal such as that involved
in CD4 lineage commitment to divert MHC class I se-
lected thymocytes to the helper cell program. The current
studies emphasize that a better understanding of signal-
ing pathways in the postselection CD4+8lo thymocytes
will be required to at long last resolve the controversy
around the mechanism of lineage specification.
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